Why is Evoq Remedies falling/rising?

As of 28-Aug, Evoq Remedies Ltd is experiencing a decline in its stock price, currently at 3.10, which reflects a decrease of 0.1 or 3.13%. The stock has been underperforming significantly, having lost 22.11% over the last six days and is trading below all key moving averages, indicating a bearish trend. Additionally, the stock has shown substantial negative returns over various periods, including a 60.26% drop year-to-date and a staggering 76.15% decline over three years. There is also a notable decrease in investor participation, with delivery volume falling by 52.38% against the five-day average, suggesting waning interest among investors. In the broader market context, Evoq Remedies' performance has been notably worse than the benchmark, with a one-week return of -14.13% compared to the Sensex's -2.34%. This stark contrast highlights the stock's struggles relative to the overall market. The stock's continued decline amidst a generally stable market environment further emphasizes its specific challenges, which are not mitigated by any positive factors, as none were provided in the data.